Latest Publications

Share:

CMS Hospital Discharge Requirements to Post-Acute Care Providers

On June 6, 2023, the Center for Medicare and Medicaid Services (CMS) provided a Quality Safety & Oversight (QSO) memorandum outlining CMS-identified concerns with respect to the patient discharge process (Memo). As set forth...more

Physical Document Examination is Dead! Long Live Physical Document Examination!

Initial Impressions of DHS' Optional Alternative 1 to the Physical Document Examination Associated with Employment Eligibility Verification (Form I-9) - Starting August 1, 2023, employers who have registered for E-Verify for...more

Forever Chemicals, Forever a Problem? PFAS Impact Business Considerations Through State and Federal Regulations

In August 2022, the Environmental Protection Agency (EPA) proposed in the Federal Register to designate two per- and poly-fluoroalkyl substances (collectively PFAS) as hazardous substances (the Proposed Rule) under the...more

Deal Killer? PFAS Impact on Commercial Real Estate Transactions

In August 2022, the Environmental Protection Agency (EPA) proposed in the Federal Register to designate Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid (collectively PFAS) as hazardous substances under the...more

Telehealth Flexibilities Get Another Shot through a Temporary Extension under the Omnibus Spending Bill

On March 15, 2022, President Biden signed the Consolidated Appropriations Act, 2022, an omnibus bill which includes, among other spending measures, a five-month extension of regulatory flexibilities that have allowed for...more

Overserved: Drug Manufacturers Attempt to Cut Off Contract Pharmacies' Access to 340B Program

Recent litigation between the federal government and drug manufacturers will surely impact how covered entities and contract pharmacies under the 340B Drug Discount Program (the 340B Program) operate going forward. A federal...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide